A potential silver lining of delaying the second dose

Nat Immunol. 2022 Mar;23(3):349-351. doi: 10.1038/s41590-022-01143-z.
No abstract available

Publication types

  • Comment

MeSH terms

  • BNT162 Vaccine*
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunity, Humoral
  • RNA, Messenger
  • T-Lymphocytes
  • Vaccination

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine